Literature DB >> 18979216

Trefoil factor-3 expression in human colon cancer liver metastasis.

Mark Babyatsky1, Jing Lin, Xianyang Yio, Anli Chen, Jie-yu Zhang, Yan Zheng, Christina Twyman, Xiuliang Bao, Myron Schwartz, Swan Thung, J Lawrence Werther, Steven Itzkowitz.   

Abstract

Deaths from colorectal cancer are often due to liver metastasis. Trefoil factor-3 (TFF3) is expressed by normal intestinal epithelial cells and its expression is maintained throughout the colon adenoma-carcinoma sequence. Our previous work demonstrated a correlation between TFF3 expression and metastatic potential in an animal model of colon cancer. The aim of this study was to determine whether TFF3 is expressed in human colon cancer liver metastasis (CCLM) and whether inhibiting TFF3 expression in colon cancer cells would alter their invasive potential in vitro. Human CCLMs were analyzed at the mRNA and protein level for TFF3 expression. Two highly metastatic rat colon cancer cell lines that either natively express TFF3 (LN cells) or were transfected with TFF3 (LPCRI-2 cells), were treated with two rat TFF3 siRNA constructs (si78 and si365), and analyzed in an in vitro invasion assay. At the mRNA and protein level, TFF3 was expressed in 17/17 (100%) CCLMs and 10/11 (91%) primary colon cancers, but not in normal liver tissue. By real time PCR, TFF3 expression was markedly inhibited by both siRNA constructs in LN and LPCRI-2 cells. The si365 and si78 constructs inhibited invasion by 44% and 53%, respectively, in LN cells, and by 74% and 50%, respectively, in LPCRI-2 cells. These results provide further evidence that TFF3 contributes to the malignant behavior of colon cancer cells. These observations may have relevance for designing new diagnostic and treatment approaches to colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18979216     DOI: 10.1007/s10585-008-9224-9

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  49 in total

1.  Analysis of gene expression profiles of gastric normal and cancer tissues by SAGE.

Authors:  Ji-Yeon Lee; Eun-Mi Eom; Dae-Sik Kim; Young Mie Ha-Lee; Dong-Hee Lee
Journal:  Genomics       Date:  2003-07       Impact factor: 5.736

2.  Amplification of chromosome 21q22.3 harboring trefoil factor family genes in liver fluke related cholangiocarcinoma is associated with poor prognosis.

Authors:  Kanuengnuch Muenphon; Temduang Limpaiboon; Patcharee Jearanaikoon; Chawalit Pairojkul; Banchob Sripa; Vajarabhongsa Bhudhisawasdi
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

3.  Intestinal trefoil factor: a marker of poor prognosis in gastric carcinoma.

Authors:  Takasuke Yamachika; J Lawrence Werther; Carol Bodian; Mark Babyatsky; Masae Tatematsu; Yoshitaka Yamamura; Anli Chen; Steven Itzkowitz
Journal:  Clin Cancer Res       Date:  2002-05       Impact factor: 12.531

4.  Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.

Authors:  Y Hippo; M Yashiro; M Ishii; H Taniguchi; S Tsutsumi; K Hirakawa; T Kodama; H Aburatani
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

5.  Intestinal trefoil factor promotes invasion in non-tumorigenic Rat-2 fibroblast cell.

Authors:  Victor Y W Chan; Michael W Y Chan; Wai-Keung Leung; Po-Sing Leung; Joseph J Y Sung; Francis K L Chan
Journal:  Regul Pept       Date:  2005-04-15

6.  Use of model cell lines to study the biosynthesis and biological role of cancer-associated sialosyl-Tn antigen.

Authors:  S gata; A Chen; S H Itzkowitz
Journal:  Cancer Res       Date:  1994-08-01       Impact factor: 12.701

7.  Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract.

Authors:  M C Rio; M P Chenard; C Wolf; L Marcellin; C Tomasetto; R Lathe; J P Bellocq; P Chambon
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

8.  Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats.

Authors:  M W Babyatsky; M deBeaumont; L Thim; D K Podolsky
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

9.  A rat model to study the role of STn antigen in colon cancer.

Authors:  S Ogata; I Ho; J Maklansky; A Chen; J L Werther; M Reddish; B M Longenecker; E Sigurdson; S Iishi; J Y Zhang; S H Itzkowitz
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

Review 10.  Are trefoil factors oncogenic?

Authors:  Jo K Perry; Nagarajan Kannan; Prudence M Grandison; Murray D Mitchell; Peter E Lobie
Journal:  Trends Endocrinol Metab       Date:  2007-12-03       Impact factor: 12.015

View more
  20 in total

1.  Trefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis.

Authors:  Thiruvengadam Arumugam; Will Brandt; Vijaya Ramachandran; Tood T Moore; Huamin Wang; Felicity E May; Bruce R Westley; Rosa F Hwang; Craig D Logsdon
Journal:  Pancreas       Date:  2011-08       Impact factor: 3.327

2.  Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma.

Authors:  Nagarajan Kannan; Jian Kang; Xiangjun Kong; Jianzhong Tang; Jo K Perry; Kumarasamypet M Mohankumar; Lance D Miller; Edison T Liu; Hichem C Mertani; Tao Zhu; Prudence M Grandison; Dong-Xu Liu; Peter E Lobie
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

3.  Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.

Authors:  Akram Yusup; Bailikezi Huji; Cheng Fang; Fei Wang; Tuerxunjiang Dadihan; Hai-Jiang Wang; Halmurat Upur
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

4.  Dietary kaempferol suppresses inflammation of dextran sulfate sodium-induced colitis in mice.

Authors:  Mi-Young Park; Geun Eog Ji; Mi-Kyung Sung
Journal:  Dig Dis Sci       Date:  2011-09-08       Impact factor: 3.199

5.  A chemoprotective fish oil- and pectin-containing diet temporally alters gene expression profiles in exfoliated rat colonocytes throughout oncogenesis.

Authors:  Youngmi Cho; Hyemee Kim; Nancy D Turner; John C Mann; Jiawei Wei; Stella S Taddeo; Laurie A Davidson; Naisyin Wang; Marina Vannucci; Raymond J Carroll; Robert S Chapkin; Joanne R Lupton
Journal:  J Nutr       Date:  2011-04-20       Impact factor: 4.798

6.  Expression of resistin-like molecule beta in gastric cancer: its relationship with clinicopathological parameters and prognosis.

Authors:  Liduan Zheng; Mixia Weng; Jun He; Xiuping Yang; Guosong Jiang; Qiangsong Tong
Journal:  Virchows Arch       Date:  2009-12-05       Impact factor: 4.064

7.  Intestinal metaplasia in liver of rats after partial hepatectomy and treatment with acetylaminofluorene.

Authors:  V Barut; C E Sarraf
Journal:  Cell Prolif       Date:  2009-07-17       Impact factor: 6.831

Review 8.  Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer.

Authors:  Wubin Zheng; Fan Wu; Kai Fu; Guangshun Sun; Guoqiang Sun; Xiao Li; Wei Jiang; Hongyong Cao; Hanjin Wang; Weiwei Tang
Journal:  Onco Targets Ther       Date:  2021-05-06       Impact factor: 4.147

9.  CD147 receptor is essential for TFF3-mediated signaling regulating colorectal cancer progression.

Authors:  Hong-Yong Cui; Shi-Jie Wang; Fei Song; Xu Cheng; Gang Nan; Yu Zhao; Mei-Rui Qian; Xi Chen; Jia-Yue Li; Fen-Ling Liu; Yu-Meng Zhu; Ruo-Fei Tian; Bin Wang; Bin Wu; Yang Zhang; Xiu-Xuan Sun; Ting Guo; Xiang-Min Yang; Hai Zhang; Ling Li; Jing Xu; Hui-Jie Bian; Jian-Li Jiang; Zhi-Nan Chen
Journal:  Signal Transduct Target Ther       Date:  2021-07-14

10.  Reduced expression of TFF1 and increased expression of TFF3 in gastric cancer: correlation with clinicopathological parameters and prognosis.

Authors:  Soyoung Im; Changyoung Yoo; Ji-Han Jung; Hyun Joo Choi; Jinyoung Yoo; Chang Suk Kang
Journal:  Int J Med Sci       Date:  2012-12-30       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.